Literature DB >> 29531907

Response to "An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs)".

Nico van Zandwijk1,2, Jennifer McDiarmid3, Himanshu Brahmbhatt3, Glen Reid2,4.   

Abstract

Entities:  

Year:  2018        PMID： 29531907      PMCID： PMC5835618          DOI： 10.21037/tlcr.2018.01.11

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  12 in total

1.  Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug.

Authors:  Jennifer A MacDiarmid; Nancy B Amaro-Mugridge; Jocelyn Madrid-Weiss; Ilya Sedliarou; Stefanie Wetzel; Kartini Kochar; Vatsala N Brahmbhatt; Leo Phillips; Scott T Pattison; Carlotta Petti; Bruce Stillman; Robert M Graham; Himanshu Brahmbhatt
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

2.  Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA.

Authors:  Adam D Judge; Vandana Sood; Janet R Shaw; Dianne Fang; Kevin McClintock; Ian MacLachlan
Journal:  Nat Biotechnol       Date:  2005-03-20       Impact factor: 54.908

3.  Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

Authors:  Nico van Zandwijk; Nick Pavlakis; Steven C Kao; Anthony Linton; Michael J Boyer; Stephen Clarke; Yennie Huynh; Agata Chrzanowska; Michael J Fulham; Dale L Bailey; Wendy A Cooper; Leonard Kritharides; Lloyd Ridley; Scott T Pattison; Jennifer MacDiarmid; Himanshu Brahmbhatt; Glen Reid
Journal:  Lancet Oncol       Date:  2017-09-01       Impact factor: 41.316

Review 4.  Is cancer gene therapy an empty suit?

Authors:  Malcolm K Brenner; Stephen Gottschalk; Ann M Leen; Juan F Vera
Journal:  Lancet Oncol       Date:  2013-10       Impact factor: 41.316

5.  Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics.

Authors:  Jennifer A MacDiarmid; Nancy B Mugridge; Jocelyn C Weiss; Leo Phillips; Adam L Burn; Richard P Paulin; Joel E Haasdyk; Kristie-Ann Dickson; Vatsala N Brahmbhatt; Scott T Pattison; Alexander C James; Ghalib Al Bakri; Rodney C Straw; Bruce Stillman; Robert M Graham; Himanshu Brahmbhatt
Journal:  Cancer Cell       Date:  2007-05       Impact factor: 31.743

6.  Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

Authors:  G Reid; M E Pel; M B Kirschner; Y Y Cheng; N Mugridge; J Weiss; M Williams; C Wright; J J B Edelman; M P Vallely; B C McCaughan; S Klebe; H Brahmbhatt; J A MacDiarmid; N van Zandwijk
Journal:  Ann Oncol       Date:  2013-10-22       Impact factor: 32.976

7.  miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma.

Authors:  Marissa Williams; Michaela B Kirschner; Yuen Yee Cheng; Jacky Hanh; Jocelyn Weiss; Nancy Mugridge; Casey M Wright; Anthony Linton; Steven C Kao; J James B Edelman; Michael P Vallely; Brian C McCaughan; Wendy Cooper; Sonja Klebe; Ruby C Y Lin; Himanshu Brahmbhatt; Jennifer MacDiarmid; Nico van Zandwijk; Glen Reid
Journal:  Oncotarget       Date:  2015-09-15

Review 8.  RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

Authors:  Zhongji Meng; Mengji Lu
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

9.  The analysis of novel microRNA mimic sequences in cancer cells reveals lack of specificity in stem-loop RT-qPCR-based microRNA detection.

Authors:  Patrick Winata; Marissa Williams; Eileen McGowan; Najah Nassif; Nico van Zandwijk; Glen Reid
Journal:  BMC Res Notes       Date:  2017-11-17

10.  MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.

Authors:  Anthony R Glover; Jing Ting Zhao; Anthony J Gill; Jocelyn Weiss; Nancy Mugridge; Edward Kim; Alex L Feeney; Julian C Ip; Glen Reid; Stephen Clarke; Patsy S H Soon; Bruce G Robinson; Himanshu Brahmbhatt; Jennifer A MacDiarmid; Stan B Sidhu
Journal:  Oncotarget       Date:  2015-11-03
View more
  4 in total

Review 1.  MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.

Authors:  Vanessa Desantis; Ilaria Saltarella; Aurelia Lamanuzzi; Assunta Melaccio; Antonio Giovanni Solimando; Maria Addolorata Mariggiò; Vito Racanelli; Angelo Paradiso; Angelo Vacca; Maria Antonia Frassanito
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 2.  microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance.

Authors:  Wen Cai Zhang
Journal:  Int J Mol Sci       Date:  2019-12-03       Impact factor: 5.923

Review 3.  The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma.

Authors:  Sara Lettieri; Chandra Bortolotto; Francesco Agustoni; Filippo Lococo; Andrea Lancia; Patrizia Comoli; Angelo G Corsico; Giulia M Stella
Journal:  J Clin Med       Date:  2021-03-03       Impact factor: 4.241

Review 4.  MicroRNA as a Potential Therapeutic Molecule in Cancer.

Authors:  Joanna Szczepanek; Monika Skorupa; Andrzej Tretyn
Journal:  Cells       Date:  2022-03-16       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.